MedTrace Logo

Accelerated Hypofractionated Whole Breast Irradiation Plus Sequential Boost Versus Concomitant Boost Following BCS

NCT03710733 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 185

Last updated 2020-09-11

No results posted yet for this study

Summary

A prospective study comparing sequential versus concomitant radiotherapy boost in breast conservative therapy.

Conditions

  • Radiotherapy Side Effect

Interventions

RADIATION

Sequential boost

Boost (10 Gy/4 fx/1 week) is given after whole breast irradiation

RADIATION

Concomitant boost

Boost (8 Gy/15 fx/3 weeks) is given with whole breast irradiation

Sponsors & Collaborators

  • National Cancer Institute, Egypt

    lead OTHER

Principal Investigators

  • Medhat El Sebaie, MD · National Cancer Institute, Egypt

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2021-06-30
Completion
2021-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03710733 on ClinicalTrials.gov